Literature DB >> 30089725

Identification of enhanced IFN-γ signaling in polyarticular juvenile idiopathic arthritis with mass cytometry.

Allison A Throm1,2, Halima Moncrieffe3,4, Amir B Orandi1, Jeanette T Pingel1, Theresa L Geurs1, Hannah L Miller5, Allyssa L Daugherty1, Olga N Malkova6, Daniel J Lovell7, Susan D Thompson3, Alexei A Grom7, Megan A Cooper1, Stephen T Oh6,8, Anthony R French1,2,5.   

Abstract

Polyarticular juvenile idiopathic arthritis (JIA) is among the most challenging of the JIA subtypes to treat. Even with current biologic therapies, the disease remains difficult to control in a substantial subset of patients, highlighting the need for new therapies. The aim of this study was to use the high dimensionality afforded by mass cytometry with phospho-specific antibodies to delineate signaling abnormalities in immune cells from treatment-naive polyarticular JIA patients. Peripheral blood mononuclear cells were isolated from 17 treatment-naive polyarticular JIA patients, 10 of the patients after achieving clinical remission, and 19 healthy controls. Samples were stimulated for 15 minutes with IL-6 or IFN-γ and analyzed by mass cytometry. Following IFN-γ stimulation, increased STAT1 and/or STAT3 phosphorylation was observed in subsets of CD4 T cells and classical monocytes from treatment-naive patients. The enhanced IFN-γ signaling was associated with increased expression of JAK1 and SOCS1 in CD4 T cells. Furthermore, substantial heterogeneity in surface marker expression was observed among the subsets of CD4 T cells and classical monocytes with increased IFN-γ responsiveness. The identification of enhanced IFN-γ signaling in CD4 T cells and classical monocytes from treatment-naive polyarticular JIA patients provides mechanistic support for investigations into therapies that attenuate IFN-γ signaling in this disease.

Entities:  

Keywords:  Autoimmune diseases; Immunology; Inflammation; Macrophages; T cells

Mesh:

Substances:

Year:  2018        PMID: 30089725      PMCID: PMC6129135          DOI: 10.1172/jci.insight.121544

Source DB:  PubMed          Journal:  JCI Insight        ISSN: 2379-3708


  45 in total

1.  Blood and synovial fluid cytokine signatures in patients with juvenile idiopathic arthritis: a cross-sectional study.

Authors:  Wilco de Jager; Esther P A H Hoppenreijs; Nico M Wulffraat; Lucy R Wedderburn; Wietse Kuis; Berent J Prakken
Journal:  Ann Rheum Dis       Date:  2006-12-14       Impact factor: 19.103

2.  Gene expression signatures in polyarticular juvenile idiopathic arthritis demonstrate disease heterogeneity and offer a molecular classification of disease subsets.

Authors:  Thomas A Griffin; Michael G Barnes; Norman T Ilowite; Judyann C Olson; David D Sherry; Beth S Gottlieb; Bruce J Aronow; Paul Pavlidis; Claas H Hinze; Sherry Thornton; Susan D Thompson; Alexei A Grom; Robert A Colbert; David N Glass
Journal:  Arthritis Rheum       Date:  2009-07

3.  Etanercept in children with polyarticular juvenile rheumatoid arthritis. Pediatric Rheumatology Collaborative Study Group.

Authors:  D J Lovell; E H Giannini; A Reiff; G D Cawkwell; E D Silverman; J J Nocton; L D Stein; A Gedalia; N T Ilowite; C A Wallace; J Whitmore; B K Finck
Journal:  N Engl J Med       Date:  2000-03-16       Impact factor: 91.245

4.  Specific deficiency of p56lck expression in T lymphocytes from type 1 diabetic patients.

Authors:  S Nervi; C Atlan-Gepner; B Kahn-Perles; P Lecine; B Vialettes; J Imbert; P Naquet
Journal:  J Immunol       Date:  2000-11-15       Impact factor: 5.422

5.  The risk and nature of flares in juvenile idiopathic arthritis: results from the ReACCh-Out cohort.

Authors:  Jaime Guzman; Kiem Oen; Adam M Huber; Karen Watanabe Duffy; Gilles Boire; Natalie Shiff; Roberta A Berard; Deborah M Levy; Elizabeth Stringer; Rosie Scuccimarri; Kimberly Morishita; Nicole Johnson; David A Cabral; Alan M Rosenberg; Maggie Larché; Paul Dancey; Ross E Petty; Ronald M Laxer; Earl Silverman; Paivi Miettunen; Anne-Laure Chetaille; Elie Haddad; Kristin Houghton; Lynn Spiegel; Stuart E Turvey; Heinrike Schmeling; Bianca Lang; Janet Ellsworth; Suzanne E Ramsey; Alessandra Bruns; Johannes Roth; Sarah Campillo; Susanne Benseler; Gaëlle Chédeville; Rayfel Schneider; Shirley M L Tse; Roxana Bolaria; Katherine Gross; Brian Feldman; Debbie Feldman; Bonnie Cameron; Roman Jurencak; Jean Dorval; Claire LeBlanc; Claire St Cyr; Michele Gibbon; Rae S M Yeung; Ciarán M Duffy; Lori B Tucker
Journal:  Ann Rheum Dis       Date:  2015-05-18       Impact factor: 19.103

6.  Radiographic progression in children with polyarticular juvenile rheumatoid arthritis: a pilot study.

Authors:  T Mason; A M Reed; A M Nelson; K B Thomas
Journal:  Ann Rheum Dis       Date:  2005-03       Impact factor: 19.103

7.  Alternative activation of STAT1 and STAT3 in response to interferon-gamma.

Authors:  Yulan Qing; George R Stark
Journal:  J Biol Chem       Date:  2004-07-27       Impact factor: 5.157

8.  Serum interleukin-6 levels and joint involvement in polyarticular and pauciarticular juvenile chronic arthritis.

Authors:  F De Benedetti; P Robbioni; M Massa; S Viola; S Albani; A Martini
Journal:  Clin Exp Rheumatol       Date:  1992 Sep-Oct       Impact factor: 4.473

9.  Adalimumab with or without methotrexate in juvenile rheumatoid arthritis.

Authors:  Daniel J Lovell; Nicolino Ruperto; Steven Goodman; Andreas Reiff; Lawrence Jung; Katerina Jarosova; Dana Nemcova; Richard Mouy; Christy Sandborg; John Bohnsack; Dirk Elewaut; Ivan Foeldvari; Valeria Gerloni; Jozef Rovensky; Kirsten Minden; Richard K Vehe; L Wagner Weiner; Gerd Horneff; Hans-Iko Huppertz; Nancy Y Olson; John R Medich; Roberto Carcereri-De-Prati; Melissa J McIlraith; Edward H Giannini; Alberto Martini
Journal:  N Engl J Med       Date:  2008-08-21       Impact factor: 91.245

10.  CD4 T-cell transcriptome analysis reveals aberrant regulation of STAT3 and Wnt signaling pathways in rheumatoid arthritis: evidence from a case-control study.

Authors:  Hua Ye; Jing Zhang; Jun Wang; Yanyan Gao; Yan Du; Chun Li; Minghua Deng; Jianping Guo; Zhanguo Li
Journal:  Arthritis Res Ther       Date:  2015-03-22       Impact factor: 5.156

View more
  5 in total

Review 1.  Using Chromatin Architecture to Understand the Genetics and Transcriptomics of Juvenile Idiopathic Arthritis.

Authors:  Haeja Kessler; Kaiyu Jiang; James N Jarvis
Journal:  Front Immunol       Date:  2018-12-14       Impact factor: 7.561

2.  CD4+ T cells from children with active juvenile idiopathic arthritis show altered chromatin features associated with transcriptional abnormalities.

Authors:  Evan Tarbell; Kaiyu Jiang; Teresa R Hennon; Lucy Holmes; Sonja Williams; Yao Fu; Patrick M Gaffney; Tao Liu; James N Jarvis
Journal:  Sci Rep       Date:  2021-02-17       Impact factor: 4.379

3.  Increased Development of Th1, Th17, and Th1.17 Cells Under T1 Polarizing Conditions in Juvenile Idiopathic Arthritis.

Authors:  Anna E Patrick; Kayla Shoaff; Tashawna Esmond; David M Patrick; David K Flaherty; T Brent Graham; Philip S Crooke; Susan Thompson; Thomas M Aune
Journal:  Front Immunol       Date:  2022-07-04       Impact factor: 8.786

4.  Analysis of chromatin data supports a role for CD14+ monocytes/macrophages in mediating genetic risk for juvenile idiopathic arthritis.

Authors:  Elizabeth A Crinzi; Emma K Haley; Kerry E Poppenberg; Kaiyu Jiang; Vincent M Tutino; James N Jarvis
Journal:  Front Immunol       Date:  2022-09-29       Impact factor: 8.786

5.  Differential Accumulation and Activation of Monocyte and Dendritic Cell Subsets in Inflamed Synovial Fluid Discriminates Between Juvenile Idiopathic Arthritis and Septic Arthritis.

Authors:  Maïlys Cren; Nadège Nziza; Aurélia Carbasse; Perrine Mahe; Emilie Dufourcq-Lopez; Marion Delpont; Hugues Chevassus; Mirna Khalil; Thibault Mura; Isabelle Duroux-Richard; Florence Apparailly; Eric Jeziorski; Pascale Louis-Plence
Journal:  Front Immunol       Date:  2020-07-31       Impact factor: 7.561

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.